These figures pool every individual call made by Stifel Nicolaus's analysts into a single sample — so a prolific analyst carries more weight than a low-volume one, exactly in proportion to the evidence available. All metrics are computed independently by 13Foresight from historical prices. Returns are measured in each stock's own trading currency, so for non-US listings the comparison against the S&P 500 does not account for currency moves — a US investor's dollar return would differ by however the exchange rate shifted.
| Analyst | Our Rank | Stars | Success | Avg Return | vs S&P | Calls |
|---|---|---|---|---|---|---|
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Cole McGill | #662 | ★★★★ | 50% | +15.3% | +41.4% | 48 |
| Alex Thompson CFA | #728 | ★★★★ | 42% | +3.4% | +32.2% | 59 |
| Shlomo Rosenbaum | #824 | ★★★★ | 51% | +1.9% | +27.2% | 73 |
| Paul Matteis | #943 | ★★★★ | 51% | +9.2% | +32.1% | 94 |
| Charlie Campbell | #1016 | ★★★ | 45% | -2.3% | +34.8% | 20 |
| J. Parker Lane | #1051 | ★★★ | 50% | +4.4% | +27.3% | 80 |
| Jeffrey Stantial | #1077 | ★★★ | 53% | -0.5% | +25.2% | 47 |
| Matthew Smith, CFA | #1167 | ★★★ | 44% | -1.6% | +22.9% | 59 |
| J. Bruce Chan | #1280 | ★★★ | 39% | -1.6% | +21.2% | 61 |
| Adam Borg | #1325 | ★★★ | 66% | +9.8% | +28.3% | 50 |
| David Grossman | #1353 | ★★★ | 54% | +5.4% | +25.1% | 57 |
| Ralph M. Profiti | #1404 | ★★★ | 51% | +1.3% | +21.3% | 97 |
| Simon Yarmak | #1466 | ★★★ | 42% | -1.1% | +19.1% | 92 |
| Brian Chin | #1500 | ★★★ | 50% | +12.2% | +31.2% | 38 |
| Brian Brophy | #1676 | ★★★ | 18% | -11.6% | +22.5% | 38 |
| Jonathan Block | #1681 | ★★★ | 51% | +4.1% | +22.6% | 63 |
| Jonathan Siegmann CFA | #1810 | ★★★ | 30% | -7.6% | +18.0% | 50 |
| James Condulis | #1856 | ★★★ | 36% | +1.0% | +31.3% | 25 |
| Tore Svanberg | #1880 | ★★★ | 42% | -1.6% | +17.0% | 77 |
| Peter McGoldrick | #1890 | ★★★ | 47% | -0.9% | +18.0% | 66 |
| Stephen Willey | #2040 | ★★★ | 49% | +0.7% | +17.3% | 81 |
| Thomas Stephan | #2044 | ★★★ | 55% | +1.5% | +19.5% | 40 |
| Stephen Gengaro | #2072 | ★★★ | 44% | +12.5% | +28.1% | 104 |
| Ruben Roy | #2074 | ★★★ | 45% | +0.7% | +17.9% | 82 |
| John Cahill | #2106 | ★★★ | 69% | +10.2% | +25.9% | 16 |
| Nathan Jones | #2125 | ★★★ | 42% | -1.1% | +13.8% | 126 |
| Steven Wieczynski | #2227 | ★★★ | 37% | -5.7% | +15.5% | 52 |
| Suthan Sukumar | #2256 | ★★ | 48% | -3.7% | +21.5% | 31 |
| Martin Landry | #2265 | ★★ | 39% | -7.7% | +13.4% | 51 |
| Daryl Young | #2283 | ★★ | 46% | +1.0% | +17.8% | 39 |
| Laura Prendergast | #2291 | ★★ | 33% | -4.6% | +22.5% | 30 |
| Brad Reback | #2319 | ★★ | 54% | +6.3% | +17.3% | 87 |
| Justin Keywood | #2353 | ★★ | 53% | -0.6% | +13.3% | 68 |
| Chris Wheaton | #2437 | ★★ | 79% | +19.0% | +29.5% | 14 |
| Ian Gillies | #2457 | ★★ | 61% | +11.2% | +17.5% | 72 |
| Christian Glennie | #2493 | ★★ | 40% | +6.0% | +29.0% | 15 |
| Annabel Samimy | #2513 | ★★ | 35% | -7.7% | +12.4% | 51 |
| W. Andrew Carter | #2528 | ★★ | 34% | -7.6% | +10.8% | 58 |
| Mark Davies Jones | #2599 | ★★ | 60% | +10.8% | +17.2% | 20 |
| Dara Azar | #2738 | ★★ | 43% | +4.1% | +21.0% | 14 |
| Erik Rasmussen | #2805 | ★★ | 47% | -3.8% | +12.0% | 17 |
| Adam Farley | #2875 | ★★ | 64% | +1.6% | +14.0% | 11 |
| Benjamin Nolan | #2893 | ★ | 81% | +39.4% | +19.2% | 31 |
| Greg MacDonald | #2928 | ★ | 33% | -1.9% | +9.8% | 18 |
| Lars Kjellberg | #3028 | ★ | 45% | -0.9% | +0.7% | 22 |
| Madison Tapscott | — | — | 80% | +429.1% | +471.6% | 5 |
The 6 top-ranked analysts at Stifel Nicolaus, the firm's full 3- and 5-year track record, and firm-vs-firm rankings across Wall Street. Everything below the top 6, plus 1- and 2-year history, stays free — Pro is what keeps this independent research running and the servers paid for.
Upgrade to ProDisclaimer: Firm-level performance is calculated independently by 13Foresight by pooling the historical calls of analysts associated with this firm, measured against market prices. It may be incomplete or delayed, is for research purposes only, and is not investment advice.